Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)

Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-015-0037-2
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chlamydia in Canada, 2010–2015

Canada Communicable Disease Report
2018English

Adverse Childhood Experiences in Alberta, Canada: A Population Based Study

Medical Research Archives
2015English

Seasonality of Childhood Tuberculosis Cases in Kampala, Uganda, 2010-2015

PLoS ONE
Multidisciplinary
2019English

Value Added

National Accounts at a Glance
2011English

Deaths Reported to National Surveillance for Adverse Events Following Immunization in China, 2010–2015

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2019English

Universal Childhood Immunization

Indian Journal of Pediatrics
Child HealthPediatricsPerinatology
1991English

Trade in Value-Added

IFDP Notes
2013English

Demand for Value Added and Value-Added Exchange Rates

IMF Working Papers
2015English

Pediatric Complicated Pneumonia Caused by Streptococcus Pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy